NeoRich BioPharma Tech Co., Limited (PHBID)
OTCMKTS · Delayed Price · Currency is USD
0.3400
+0.0060 (1.80%)
At close: Aug 19, 2026
NeoRich BioPharma Tech Revenue
NeoRich BioPharma Tech had revenue of $828.00 in the quarter ending December 31, 2024, a decrease of -33.01%. This brings the company's revenue in the last twelve months to $3.00K, down -29.10% year-over-year. In the fiscal year ending September 30, 2024, NeoRich BioPharma Tech had annual revenue of $3.41K with 13.74% growth.
Revenue (ttm)
3.00K
Revenue Growth
-29.10%
P/S Ratio
39.15
Revenue / Employee
n/a
Employees
n/a
Market Cap
117.53K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 3.41K | 412.00 | 13.74% |
| Sep 30, 2023 | 3.00K | - | - |
| Sep 30, 2022 | - | - | - |
| Sep 30, 2021 | - | - | - |
| Sep 30, 2020 | - | - | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Mystic Holdings | 21.40M |
| Petros Pharmaceuticals | 5.11M |
| Tristar Wellness Solutions | 4.00M |
| Resonate Blends | 2.23M |
| CannLabs | 1.72M |
| ViaDerma | 44.69K |
| Grapefruit USA | 34.85K |
| Kaya Holdings | 26.69K |
NeoRich BioPharma Tech News
- 2 years ago - Pharmagreen Biotech Inc. (PHBI) Announces Exciting Revenue Potential for Its Project - GlobeNewsWire
- 2 years ago - Pharmagreen Biotech, Inc. (PHBI) Reaffirms Commitment to Non-Toxic Financing Amid Ongoing Business Development Progress - GlobeNewsWire
- 2 years ago - PHBI - Pharmagreen Signs Supply Contract and Trade Marked Name Use of SierraSil(R) in Its' Nutraceutical Formulations - Accesswire
- 3 years ago - PHBI Pharmgreen Launches Online Sales for Its MaxGenomic™ Supplement Product - GlobeNewsWire
- 4 years ago - PHBI Pharmagreen Biotech Appoints Ethan Styles as Vice President of Product Research and Development - GlobeNewsWire
- 4 years ago - PHBI Pharmagreen Develops a Proprietary Nutraceutical Formulation and Prepares for Product Launch - GlobeNewsWire
- 4 years ago - PHBI – Pharmagreen Provides Updates On Its Business Developments Beyond Just Cannabis - GlobeNewsWire
- 4 years ago - PHBI Pharmagreen Announces Another Milestone Completed Towards the Acquisition of Long Valley Farms LLC - GlobeNewsWire